Yakob Liawatidewi - 13 Apr 2023 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
13 Apr 2023
Net transactions value
-$245,224
Form type
4
Filing time
14 Apr 2023, 17:50:00 UTC
Previous filing
12 Apr 2023
Next filing
06 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $232,524 +11,494 +17% $20.23 80,709 13 Apr 2023 Direct
transaction AMPH Common Stock Sale $205,000 -5,000 -6.2% $41.00 75,709 13 Apr 2023 Direct F1
transaction AMPH Common Stock Sale $272,748 -6,494 -8.6% $42.00 69,215 13 Apr 2023 Direct F1
holding AMPH Common Stock 2,459 13 Apr 2023 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -11,494 -68% $0.000000 5,497 13 Apr 2023 Common Stock 11,494 $20.23 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2022.
F2 The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
F3 Shares subject to the option vest in four equal annual installments beginning on March 15, 2020.